Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
There are no as such competitors for Ovid Therapeutics.
Ovid Therapeutics has a consensus price target of $3.91.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $2.3 last updated June 18, 2026 at 7:18 PM EDT.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.